Sarah McMillan
Nurse Practitioner · Lawrenceville, GANPI 1962017343
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $174 of the $253 with a category attached, or 69.0%. Stryker accounts for 69.0% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $174, 5.2 times the $34 reported in 2021.
Across 5 payments — averaging $50.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$174
- Amgen$25
- Alkermes, Inc.$20
- Fresenius USA Marketing, Inc.$19
- Otsuka America Pharmaceutical, Inc.$14
What the payments were for
- Travel & lodging$17469%
- Food & beverage$7831%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 1 | $174 |
| Amgen | 1 | $25 |
| Alkermes, Inc. | 1 | $20 |
| Fresenius USA Marketing, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CORE$174
How this compares
$253 in reported general payments places this provider in the 55th percentile of 3,328 nurse practitioner providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 143 | $95,688 |
| Austedo XrDeutetrabenazine | 11 | $79,244 |
| XareltoRivaroxaban | 37 | $23,427 |
| JardianceEmpagliflozin | 28 | $16,964 |
| Breo ElliptaFluticasone/Vilanterol | 27 | $14,028 |
| EntrestoSacubitril/Valsartan | 24 | $13,035 |
| Memantine Hcl | 114 | $6,294 |
| Spiriva RespimatTiotropium Bromide | 11 | $6,025 |
| Colesevelam Hcl | 12 | $4,796 |
| VascepaIcosapent Ethyl | 16 | $3,354 |
| Dexlansoprazole DrDexlansoprazole | 12 | $3,104 |
| Aripiprazole | 19 | $2,695 |
| Gabapentin | 188 | $2,350 |
| Mirtazapine | 84 | $2,347 |
| Atorvastatin Calcium | 225 | $2,236 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Lawrenceville
- Hyacinth ThomasLawrenceville$19K
- Tracy PerryLawrenceville$14K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Tajuana BradleyJohns Creek$256K
- Jessica AdkinsSavannah$226K
- Janice McAlisterAtlanta$221K
- Laura ElledgeAtlanta$177K
- Afsha HussainiKennesaw$122K
- Elizabeth TyeAlbany$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.